MovDisordV3, Main, Exploration, bibRecordById, Pascal:10-0491608

Neuroleptic malignant syndrome with aripiprazole in Huntington's disease

Identifieur interne : 001B58 ( Main/Exploration ); précédent : 001B57; suivant : 001B59

Neuroleptic malignant syndrome with aripiprazole in Huntington's disease

Auteurs : Maximilian Gahr [Allemagne] ; Michael Orth [Allemagne] ; Birgit Abler [Allemagne]

Source :

Movement Disorders [ 0885-3185 ] ; 2010-10-30.

RBID : ISTEX:6D55D03229E0CB22E467139116A1D800D91BC592

Descripteurs français

Pascal (Inist)
- Aripiprazole, Chorée de Huntington, Pathologie du système nerveux, Syndrome malin.

English descriptors

KwdEn :
- Antipsychotic Agents (adverse effects), Aripiprazole, Humans, Huntington Disease (drug therapy), Huntington disease, Male, Malignant syndrome, Middle Aged, Nervous system diseases, Neuroleptic Malignant Syndrome (etiology), Piperazines (adverse effects), Quinolones (adverse effects).
MESH :
- chemical , adverse effects : Antipsychotic Agents, Piperazines, Quinolones.
- drug therapy : Huntington Disease.
- etiology : Neuroleptic Malignant Syndrome.
- Humans, Male, Middle Aged.

Url:

https://api.istex.fr/document/6D55D03229E0CB22E467139116A1D800D91BC592/fulltext/pdf

DOI: 10.1002/mds.23332

Affiliations:

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Neuroleptic malignant syndrome with aripiprazole in Huntington's disease</title>
<author><name sortKey="Gahr, Maximilian" sort="Gahr, Maximilian" uniqKey="Gahr M" first="Maximilian" last="Gahr">Maximilian Gahr</name>
</author>
<author><name sortKey="Orth, Michael" sort="Orth, Michael" uniqKey="Orth M" first="Michael" last="Orth">Michael Orth</name>
</author>
<author><name sortKey="Abler, Birgit" sort="Abler, Birgit" uniqKey="Abler B" first="Birgit" last="Abler">Birgit Abler</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:6D55D03229E0CB22E467139116A1D800D91BC592</idno>
<date when="2010" year="2010">2010</date>
<idno type="doi">10.1002/mds.23332</idno>
<idno type="url">https://api.istex.fr/document/6D55D03229E0CB22E467139116A1D800D91BC592/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002296</idno>
<idno type="wicri:Area/Istex/Curation">002296</idno>
<idno type="wicri:Area/Istex/Checkpoint">000837</idno>
<idno type="wicri:doubleKey">0885-3185:2010:Gahr M:neuroleptic:malignant:syndrome</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:20669301</idno>
<idno type="wicri:Area/PubMed/Corpus">001670</idno>
<idno type="wicri:Area/PubMed/Curation">001670</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001755</idno>
<idno type="wicri:Area/Ncbi/Merge">002D47</idno>
<idno type="wicri:Area/Ncbi/Curation">002D47</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002D47</idno>
<idno type="wicri:Area/Main/Merge">001F94</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:10-0491608</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000835</idno>
<idno type="wicri:Area/PascalFrancis/Curation">002484</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000947</idno>
<idno type="wicri:doubleKey">0885-3185:2010:Gahr M:neuroleptic:malignant:syndrome</idno>
<idno type="wicri:Area/Main/Merge">002534</idno>
<idno type="wicri:Area/Main/Curation">001B58</idno>
<idno type="wicri:Area/Main/Exploration">001B58</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Neuroleptic malignant syndrome with aripiprazole in Huntington's disease</title>
<author><name sortKey="Gahr, Maximilian" sort="Gahr, Maximilian" uniqKey="Gahr M" first="Maximilian" last="Gahr">Maximilian Gahr</name>
<affiliation wicri:level="4"><country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Psychiatry, University of Ulm, Leimgrubenweg 12‐14, Ulm 89075</wicri:regionArea>
<placeName><region type="land" nuts="1">Bade-Wurtemberg</region>
<region type="district" nuts="2">District de Tübingen</region>
<settlement type="city">Ulm</settlement>
</placeName>
<orgName type="university">Université d'Ulm</orgName>
</affiliation>
</author>
<author><name sortKey="Orth, Michael" sort="Orth, Michael" uniqKey="Orth M" first="Michael" last="Orth">Michael Orth</name>
<affiliation wicri:level="4"><country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurology, University of Ulm, Leimgrubenweg 12‐14, Ulm 89075</wicri:regionArea>
<placeName><region type="land" nuts="1">Bade-Wurtemberg</region>
<region type="district" nuts="2">District de Tübingen</region>
<settlement type="city">Ulm</settlement>
</placeName>
<orgName type="university">Université d'Ulm</orgName>
</affiliation>
</author>
<author><name sortKey="Abler, Birgit" sort="Abler, Birgit" uniqKey="Abler B" first="Birgit" last="Abler">Birgit Abler</name>
<affiliation wicri:level="4"><country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Psychiatry, University of Ulm, Leimgrubenweg 12‐14, Ulm 89075</wicri:regionArea>
<placeName><region type="land" nuts="1">Bade-Wurtemberg</region>
<region type="district" nuts="2">District de Tübingen</region>
<settlement type="city">Ulm</settlement>
</placeName>
<orgName type="university">Université d'Ulm</orgName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2010-10-30">2010-10-30</date>
<biblScope unit="vol">25</biblScope>
<biblScope unit="issue">14</biblScope>
<biblScope unit="page" from="2475">2475</biblScope>
<biblScope unit="page" to="2476">2476</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">6D55D03229E0CB22E467139116A1D800D91BC592</idno>
<idno type="DOI">10.1002/mds.23332</idno>
<idno type="ArticleID">MDS23332</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antipsychotic Agents (adverse effects)</term>
<term>Aripiprazole</term>
<term>Humans</term>
<term>Huntington Disease (drug therapy)</term>
<term>Huntington disease</term>
<term>Male</term>
<term>Malignant syndrome</term>
<term>Middle Aged</term>
<term>Nervous system diseases</term>
<term>Neuroleptic Malignant Syndrome (etiology)</term>
<term>Piperazines (adverse effects)</term>
<term>Quinolones (adverse effects)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antipsychotic Agents</term>
<term>Piperazines</term>
<term>Quinolones</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Huntington Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Neuroleptic Malignant Syndrome</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Aripiprazole</term>
<term>Chorée de Huntington</term>
<term>Pathologie du   système nerveux</term>
<term>Syndrome malin</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list><country><li>Allemagne</li>
</country>
<region><li>Bade-Wurtemberg</li>
<li>District de Tübingen</li>
</region>
<settlement><li>Ulm</li>
</settlement>
<orgName><li>Université d'Ulm</li>
</orgName>
</list>
<tree><country name="Allemagne"><region name="Bade-Wurtemberg"><name sortKey="Gahr, Maximilian" sort="Gahr, Maximilian" uniqKey="Gahr M" first="Maximilian" last="Gahr">Maximilian Gahr</name>
</region>
<name sortKey="Abler, Birgit" sort="Abler, Birgit" uniqKey="Abler B" first="Birgit" last="Abler">Birgit Abler</name>
<name sortKey="Orth, Michael" sort="Orth, Michael" uniqKey="Orth M" first="Michael" last="Orth">Michael Orth</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001B58 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001B58 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:6D55D03229E0CB22E467139116A1D800D91BC592
   |texte=   Neuroleptic malignant syndrome with aripiprazole in Huntington's disease
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

Movement Disorders (revue)

Neuroleptic malignant syndrome with aripiprazole in Huntington's disease

Neuroleptic malignant syndrome with aripiprazole in Huntington's disease

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.